For the Inventor, By the Inventor

Enter assignee name

Atlanta, GA, United States of America

Vero Biotech Inc.

USPTO Granted Patents = 38

% Expired Patents = 2.6

CIPO Patents = 4

EPO Patents = 8

Trademarks = 2

Forward Citations = 223

Loading Chart...

Loading Chart...

23 inventors (with patents filed for the assignee):

David H Fine (38 out of 129 patents)

Gregory Vasquez (18 out of 33 patents)

Bryan J Johnson (17 out of 29 patents)

4. Ryan Denton (12 out of 15 patents)

5. David P Rounbehler (11 out of 59 patents)

6. Lucas G Gamero (9 out of 11 patents)

7. Edward Bromberg (8 out of 10 patents)

8. Thorsten Schmidt (6 out of 6 patents)

9. Barry N Gellman (3 out of 4 patents)

10. Joshua Hopkins (3 out of 12 patents)

11. Edward E A Bromberg (3 out of 8 patents)

12. Alessandra Miranda (2 out of 2 patents)

13. Marjorie Nelson (2 out of 2 patents)

14. David R Rounbehler (2 out of 13 patents)

15. Jason White (2 out of 2 patents)

Core Competencies:

Nitric Oxide

Gas Calibration

Delivery Device

Nitrogen Dioxide

Portable Delivery

Ultra Pure Nitric Oxide

Vasoreactivity

High-Altitude Sickness

Nitrogen Tetroxide

Concentration Sensors

Heart Condition Treatment

Start-Up Protocols

38 patents: Sort by Forward Citations

1. 12679729 - Conversion of nitrogen dioxide (NO) to nitric oxide (NO) (2026-07-14),

2. 12661477 - Nitric oxide therapies (2026-06-23),

3. 12605520 - Delivery of ultra pure nitric oxide (NO) (2026-04-21),

4. 12544527 - Start-up protocols for nitric oxide delivery device (2026-02-10),

5. 12461079 - Method and apparatus for calibration of gas and liquid concentration sensors without the need for known calibration standards (2025-11-04),

6. 12350434 - Nitrogen dioxide storage device (2025-07-08),

7. 12186486 - Apparatus and method for portable nitric oxide delivery (2025-01-07),

8. 12172890 - Method and apparatus for manufacturing nitrogen tetroxide (2024-12-24),

9. 12171948 - Systems and devices for generating nitric oxide (2024-12-24),

10. 12059661 - Conversion of nitrogen dioxide (NO) to nitric oxide (NO) (2024-08-13),

11. 11925764 - Nitric oxide therapies (2024-03-12),

12. 11884541 - Conversion of nitrogen dioxide (NO) to nitric oxide (NO) (2024-01-30),

13. 11779725 - Nitrogen dioxide storage device (2023-10-10),

14. 11754538 - Method and apparatus for automatic calibration (2023-09-12),

15. 11744978 - Systems and devices for generating nitric oxide (2023-09-05),

Vero Biotech Inc. is a biotechnology company based in Atlanta, Georgia, specializing in the development of innovative therapies for respiratory diseases. The company focuses on creating advanced drug delivery systems that enhance the efficacy of existing treatments. Vero Biotech is committed to improving patient outcomes through its proprietary technologies, which aim to address unmet medical needs in the field of pulmonary medicine. Their research emphasizes the integration of science and technology to foster better health solutions.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

38 Patents

#82 in Atlanta, GA

#187 in Georgia

#9,014 in US

#17,815 in the World

Atlanta, GA, United States of America

Vero Biotech Inc.

Forward Citations = 223

23 inventors:

David H Fine (38 out of 129 patents)

Gregory Vasquez (18 out of 33 patents)

Bryan J Johnson (17 out of 29 patents)

4. Ryan Denton (12 out of 15 patents)

5. David P Rounbehler (11 out of 59 patents)

Please report any incorrect information to [email protected]

Loading…